Redmond Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.29M Sell
19,017
-5,731
-23% -$662K 0.62% 52
2025
Q4
$2.6M Sell
24,748
-301
-1% -$28.3K 0.66% 48
2025
Q3
$2.1M Sell
25,049
-300
-1% -$24.7K 0.52% 66
2025
Q2
$2.01M Buy
25,349
+8,391
+49% +$667K 0.48% 72
2025
Q1
$1.52M Buy
16,958
+1,668
+11% +$156K 0.39% 82
2024
Q4
$1.52M Buy
15,290
+4,092
+37% +$422K 0.38% 89
2024
Q3
$1.27M Buy
11,198
+809
+8% +$96.1K 0.4% 82
2024
Q2
$1.29M Sell
10,389
-82
-0.8% -$10.6K 0.42% 83
2024
Q1
$1.38M Sell
10,471
-498
-5% -$61.4K 0.44% 84
2023
Q4
$1.2M Buy
10,969
+611
+6% +$63.4K 0.39% 92
2023
Q3
$1.07M Sell
10,358
-60
-0.6% -$6.47K 0.38% 87
2023
Q2
$1.2M Sell
10,418
-146
-1% -$16.6K 0.39% 84
2023
Q1
$1.12M Sell
10,564
-1,551
-13% -$167K 0.39% 90
2022
Q4
$1.34M Sell
12,115
-3,137
-21% -$321K 0.48% 75
2022
Q3
$1.31M Sell
15,252
-714
-4% -$63.7K 0.49% 70
2022
Q2
$1.46M Buy
15,966
+2
+0% +$177 0.52% 64
2022
Q1
$1.31M Buy
15,964
+1,484
+10% +$117K 0.39% 90
2021
Q4
$1.11M Buy
14,480
+2,710
+23% +$216K 0.31% 115
2021
Q3
$884K Buy
11,770
+1
+0% +$76 0.28% 115
2021
Q2
$915K Sell
11,769
-1,425
-11% -$106K 0.27% 120
2021
Q1
$970K Buy
13,194
+209
+2% +$15.4K 0.3% 113
2020
Q4
$1.01M Buy
12,985
+1,230
+10% +$94.1K 0.36% 96
2020
Q3
$930K Buy
11,755
+1,301
+12% +$102K 0.39% 84
2020
Q2
$771K Buy
10,454
+415
+4% +$31.2K 0.32% 95
2020
Q1
$737K Buy
10,039
+1,466
+17% +$115K 0.37% 82
2019
Q4
$743K Buy
8,573
+26
+0.3% +$2.14K 0.32% 98
2019
Q3
$687K Buy
8,547
+1,610
+23% +$129K 0.3% 100
2019
Q2
$555K Buy
6,937
+116
+2% +$8.88K 0.24% 121
2019
Q1
$541K Buy
6,821
+953
+16% +$71.3K 0.24% 120
2018
Q4
$428K Sell
5,868
-121
-2% -$8.54K 0.2% 128
2018
Q3
$405K Hold
5,989
0.16% 139
2018
Q2
$347K Buy
5,989
+943
+19% +$53.2K 0.15% 143
2018
Q1
$262K Sell
5,046
-155
-3% -$8.37K 0.12% 155
2017
Q4
$279K Buy
5,201
+165
+3% +$9.15K 0.12% 155
2017
Q3
$308K Sell
5,036
-644
-11% -$39K 0.14% 142
2017
Q2
$347K Buy
+5,680
New +$346K 0.16% 138

Other funds holding MRK

Redmond Asset Management's MRK Position: Q1 2026 in Review

Redmond Asset Management reduced its Merck (MRK) stake by 23% in Q1 2026, selling an estimated $662K and leaving 19,017 shares worth $2.29M. The position accounts for 0.62% of the portfolio, ranked #52.

Redmond Asset Management first reported a position in MRK in Q2 2017 and has held it in 36 quarters since. The position peaked at $2.6M in Q4 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Redmond Asset Management held 19,017 shares of Merck worth $2.29M as of Q1 2026.
  • Redmond Asset Management sold 5,731 Merck shares in Q1 2026, an estimated $662K.
  • Merck made up 0.62% of Redmond Asset Management's portfolio in Q1 2026, its #52 holding.
  • Redmond Asset Management first reported a position in Merck in Q2 2017 and has held it in 36 quarters since.
  • Redmond Asset Management's Merck position peaked at $2.6M in Q4 2025.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Redmond Asset Management's 13F filing for Q1 2026, filed 6 May 2026.